ArticleSensors (Basel, Switzerland)2025
Molecularly Imprinted Membranes: Dual@MIPs@mbr for On-Site Detection of CA 19-9.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dual-emission molecularly imprinted membranes (dual@MIPs@mbr) were developed as a proof-of-concept platform for the selective and instrument-free detection of the cancer biomarker carbohydrate antigen 19-9 (CA 19-9). The system integrates a ratiometric fluorescence response by embedding yellow-emitting quantum dots (y-QDs), serving as target-responsive probes, and blue-emitting carbon dots (b-CDs), acting as an internal reference, within a CA 19-9-imprinted polymeric matrix. Specific rebinding of CA 19-9 to the imprinted cavities induced selective quenching of the y-QDs while preserving the b-CDs emission, yielding a visible color shift from yellow/green to blue. This behavior enabled the quantification of CA 19-9 over a linear range of 4-400 U mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.